A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has Spread

NCT02060188 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

385

Enrollment

INDUSTRY

Sponsor class

Conditions

Microsatellite Unstable Colorectal Cancer
Microsatellite Stable Colorectal Cancer
Mismatch Repair Proficient Colorectal Cancer
Mismatch Repair Deficient Colorectal Cancer

Interventions

DRUG: Ipilimumab
DRUG: Nivolumab
DRUG: Cobimetinib
DRUG: Daratumumab
DRUG: BMS-986016

Sponsor

Bristol-Myers Squibb